A cushion assembly for a patient interface including an elastomeric seal-forming structure that is shaped to be bisected by a sagittal plane having a line that is tangent to the elastomeric seal-forming structure at a superior tangent point and at an inferior tangent point. A saddle-shaped superior region of the elastomeric seal-forming structure straddles the sagittal plane and includes the superior tangent point. The elastomeric seal-forming structure transitions in a cylinder-shaped superior region from the saddle-shaped region to a dome-shaped superior region offset from the sagittal plane. In addition, an elastomeric wall thickness of the elastomeric seal-forming structure is greater in the cylinder-shaped superior region than in the saddle-shaped superior region and the dome-shaped superior region.

A patient interface includes a frame including a textile material and a seal-forming structure provided to the frame. The seal-forming structure includes a foam material and/or a foam and textile material configured and arranged to form a seal with the patient's nose and/or mouth.

A patient interface includes a frame including a textile material and a seal-forming structure provided to the frame. The seal-forming structure includes a foam material and/or a foam and textile material configured and arranged to form a seal with the patient's nose and/or mouth.

Aspects of the present technology comprise a positioning and stabilising structure to hold a seal-forming structure in a therapeutically effective position on a head of a patient. The seal-forming structure may be constructed and arranged to form a seal with a region of the patient's face surrounding an entrance to the patient's airways for sealed delivery of a flow of air at a therapeutic pressure of at least 4 cmH.sub.2O with respect to ambient air pressure throughout the patient's respiratory cycle in use. The positioning and stabilising structure may comprise a front hoop arranged to contact, in use, at least a region of the patient's head superior to an otobasion superior of the patient's head and a rear strap. The positioning and stabilising structure may comprise an adjustment mechanism for adjustment of the front hoop and the rear strap relative to the patient's head, the adjustment mechanism being arranged in a single operation to adjust both the front hoop and rear strap to enable the positioning and stabilising structure to fit different size heads.

Aspects of the present technology comprise a positioning and stabilising structure to hold a seal-forming structure in a therapeutically effective position on a head of a patient. The seal-forming structure may be constructed and arranged to form a seal with a region of the patient's face surrounding an entrance to the patient's airways for sealed delivery of a flow of air at a therapeutic pressure of at least 4 cmH.sub.2O with respect to ambient air pressure throughout the patient's respiratory cycle in use. The positioning and stabilising structure may comprise a front hoop arranged to contact, in use, at least a region of the patient's head superior to an otobasion superior of the patient's head and a rear strap. The positioning and stabilising structure may comprise an adjustment mechanism for adjustment of the front hoop and the rear strap relative to the patient's head, the adjustment mechanism being arranged in a single operation to adjust both the front hoop and rear strap to enable the positioning and stabilising structure to fit different size heads.

An anatomical probe system comprises an elongated flexible body and an operational component extending within a channel of the flexible body. The system also comprises a support member at a distal end of the elongated flexible body. The support member includes a fluid director adapted to direct a fluid from the channel toward the operational component. The fluid may be automatically directed towards the operational component in response to detecting a material obstruction of an image.

According to this disclosure there is provided a respiratory support apparatus configured to provide a gases flow to a patient, the respiratory support apparatus comprising: a flow generator configured to generate the gases flow; a humidifier configured to humidify the gases flow; and a controller. The apparatus is controlled by the controller to function in at least two modes, being a normal mode and a high-temperature mode. In the high-temperature mode the temperature of gases delivered to the patient is higher than the temperature of gases delivered to the patient when in the normal mode. In the high-temperature mode, the controller controls one or more parameters of the gases flow to be different to that in the normal mode, whilst providing higher temperatures. The apparatus is also operative in a cool-down mode in which one or more parameters of the gases flow are controlled. The apparatus includes safety features to ensure the temperature, dew-point, enthalpy, and/or energy of the gases flow do not exceed safe limits.

A connector having a connector body with an inlet and an outlet defining a gas flow passage therebetween. The connector body has an overlap portion that is configured to overlap with a portion of a second connector when connected. An access passage extends through the overlap portion to the gas flow passage.

A connector having a connector body with an inlet and an outlet defining a gas flow passage therebetween. The connector body has an overlap portion that is configured to overlap with a portion of a second connector when connected. An access passage extends through the overlap portion to the gas flow passage.

The present disclosure is directed to systems and methods of providing a mixed-gas inhalant to a patient via a gas recirculation loop. The gas recirculation loop receives a first mixed-gas exhalant having a first carbon dioxide concentration from the patient, one or more carbon dioxide removal devices discharge a second mixed-gas exhalant having a second carbon dioxide concentration that is less than the first carbon dioxide concentration. The second mixed-gas exhalant is combined with a mixed-gas supply to provide a mixed-gas inhalant. The mied-gas supply includes a first gas and a second gas. The mixed-gas supply is pressure and flow controlled to produce a mixed-gas inhalant having a defined composition delivered to the patient at a defined volumetric flow rate. The first gas may include a gas containing oxygen and the second gas may include a gas mixture containing a noble or inert gas and oxygen.